All relevant data are within the paper and its Supporting Information files. The adRP genotyping Asper Ophthalmics microarray (Asper Biotech) is a commercially available genotyping microarray chip based on APEX technology (Asper Biotech, Tartu, Estonia). The Asper Biotech array checks for the presence of 414 markers in 16 genes related to adRP. The list of these mutations is available to all the interested researchers using the hyperlink: <http://www.asperbio.com/asper-ophthalmics/autosomal-dominant-retinitis-pigmentosa-genetic-testing>.

Introduction {#sec006}
============

Retinitis Pigmentosa (RP, MIM\# 268000), with a prevalence of approximately one in 4000 \[[@pone.0149473.ref001]\], is the most common form of inherited retinopathy. RP is a group of clinically and genetically heterogeneous retinal degenerative diseases. Clinically it is characterized by progressive loss of photoreceptors and pigment deposits predominantly in the peripheral retina, and by a relative sparing of the central retina. The diagnostic criteria for RP were established by Marmor \[[@pone.0149473.ref002]--[@pone.0149473.ref005]\]. To date, sixty-nine genes have been associated with non-syndromic RP (<http://www.sph.uth.tmc.edu/RetNet/>, data accessed 30/12/2015) and all modes of inheritance have been described in this disease: autosomal dominant, autosomal recessive, X linked, mitochondrial and, in rare cases, digenic \[[@pone.0149473.ref006]\].

In Spain, autosomal dominant form of RP (adRP) represents approximately 15% of Spanish RP families \[[@pone.0149473.ref007], [@pone.0149473.ref008]\]. The large number of genes involved in adRP disease complicates genetic analysis of these patients. To date, 23 genes (and one mapped locus) have been associated with adRP (<http://www.sph.uth.tmc.edu/RetNet/>, data accessed 30/12/2015). One of these 23 genes is the *NR2E3* gene, which contains eight exons that expand a genomic sequence of around 7.7 kilobases (kb). The open reading frame of this gene encodes for a retinal nuclear receptor protein that acts as a transcriptional regulator, activating rod-specific genes in concert with other transcriptional factors (CRX and NRL), as well as repressing the transcription of cone-specific genes in differentiating rod photoreceptors \[[@pone.0149473.ref009]\].

Most of the mutations in this gene have been associated with autosomal recessive retinitis pigmentosa (arRP) with variable phenotypes (enhanced S-cone sensitivity syndrome -ESCS- \[[@pone.0149473.ref010], [@pone.0149473.ref011]\], Goldmann-Favre syndrome -GFS- \[[@pone.0149473.ref012]\], and clumped pigmentary retinal degeneration -CPRD-) \[[@pone.0149473.ref013]--[@pone.0149473.ref016]\]. However, one mutation (p.Gly56Arg) in the first zinc-finger of the DNA binding domain of the *NR2E3* gene has been found in adRP patients \[[@pone.0149473.ref017]\] associated with RP phenotype (progressive rod degeneration and ulterior cone affectation) \[[@pone.0149473.ref018]\]. This mutation accounts for approximately 1--2% of North American and 3.4% of European adRP patients \[[@pone.0149473.ref017]--[@pone.0149473.ref019]\], and, until present time, is the only mutation found in the *NR2E3* gene responsible for adRP \[[@pone.0149473.ref017]--[@pone.0149473.ref021]\].

The aim of this study is to analyse the frequency of the p.Gly56Arg mutation in the *NR2E3* gene in our cohort of adRP patients and to determine the associated phenotype.

Patients and Methods {#sec007}
====================

Patients {#sec008}
--------

The adRP diagnosis was based on pedigree data and ophthalmologic examination. Our patients were classified as affected by RP according to the following clinical criteria: night blindness (NB), progressive loss of peripheral vision (mid peripheral scotoma or ring scotoma), fundus compatible with RP \[[@pone.0149473.ref003], [@pone.0149473.ref004]\] (ophthalmoscopic examination after pupillary dilation), and pathologic electroretinogram (ERG) showing a marked reduction in rod or rod and cone signal (full-field electroretinogram according to the standards of the International Society for Clinical Electrophysiology of Vision: [http://www.iscev.org](http://www.iscev.org/)) \[[@pone.0149473.ref022]\]. Autosomal dominant inheritance was considered according to previously established criteria \[[@pone.0149473.ref007], [@pone.0149473.ref008]\].

The severity of visual acuity loss was classified following the WHO criteria (normal vision ≥0.4, moderate low vision \<0.4 --\>0.1, severe low vision ≤0.1 - ≥0.05, and profound vision loss and blindness \<0.05)

Written informed consent was obtained from all individuals included in the study and research protocols were approved by the Ethics committee of the University Hospital Fundación Jiménez Díaz in accordance with the tenets of the Declaration of Helsinki and their reviews.

Screening for *NR2E3* autosomal dominant mutation {#sec009}
-------------------------------------------------

DNA was extracted from peripheral blood samples and collected in EDTA tubes using an automated DNA extractor according to manufacturer instructions (model BioRobot EZ1; Qiagen, Hilden, Germany).

The p.Gly56Arg mutation in the *NR2E3* gene (NM_014249.2) was analysed in a total of 201 unrelated adRP families. The analysis was performed by direct sequencing, as previously reported \[[@pone.0149473.ref019]\], or by adRP genotyping Asper Ophthalmics microarray (Asper Biotech \[[@pone.0149473.ref019]\], <http://www.asperbio.com/asper-ophthalmics/autosomal-dominant-retinitis-pigmentosa-ad-rp/autosomal-dominant-retinitis-pigmentosa-targeted-mutation-analysis>, versions from February 2008 to July 2014).

Among 201 families, 60 had been studied previously, showing a negative result, using the first version of the adRP genotyping microarray, which did not include the p.Gly56Arg mutation \[[@pone.0149473.ref023]\]. The remaining 141 families underwent an updated version of the adRP genotyping microarray which included the p.Gly56Arg mutation in the *NR2E3* gene. Direct sequencing was used to analyse the 60 previously studied families, to confirm the results obtained with the genotyping microarray and to segregate the disease causative mutation p.Gly56Arg in the *NR2E3* gene in the families.

Haplotype Analysis {#sec010}
------------------

Haplotype analysis was performed using four extragenic polymorphic markers (*NR2E3* genomic position according to Human Genome Assembly GRCh37, Chr15: 72,084,977--72,110,600) strongly linked to this locus: D15S967, D15S1050, D15S204, and D15S188. For the genotyping process, PCR products were electrophoresed in an ABI Prism 3130 Genetic Analyzer and analyzed with the GeneMapper v3.5 software package (Applied Biosystems).

An *in silico* analysis was performed using the Hapmap/Haploview 4.0 software (<http://www.hapmap.org/>) to establish the linkage disequilibrium blocks (D´ and r2 parameters) in the genomic region between D15S1050 and the *NR2E3* gene ([Fig 1](#pone.0149473.g001){ref-type="fig"}).

![Linkage disequilibrium for region Chr15: 71,980,969--72,110,600 of the Human Genome Assembly GRCh37 (Hapmap/Haploview 4.0 software: <http://www.hapmap.org/>).\
Colour image: D´ (red: D´ = 1, the lower the D´ the further away from red). Black & white image: r^2^ (black: r^2^, the lower the r^2^ the further away from black).](pone.0149473.g001){#pone.0149473.g001}

Results {#sec011}
=======

Seven out of 201 adRP studied families were positive for the p.Gly56Arg mutation in the *NR2E3* gene (five of them identified by direct sequencing of the mutation and two by the adRP genotyping microarray).

The detection of the dominant *NR2E3* mutation in seven families, gives us a frequency of 3.5% (7/201) in our adRP studied cohort. All families were of Spanish origin except RP-1650 which was from Venezuela (both grandparents from mother´s side--disease origin--were Venezuelan).

Phenotypic characteristics of *NR2E3* mutation {#sec012}
----------------------------------------------

Clinical data were available for 24 subjects from the seven *NR2E3* mutated adRP families ([Table 1](#pone.0149473.t001){ref-type="table"}).

10.1371/journal.pone.0149473.t001

###### Clinical data of 24 affected cases presenting the p.Gly56Arg mutation in the *NR2E3* gene.

![](pone.0149473.t001){#pone.0149473.t001g}

  Individual   Family    Year of birth   Age at diagnostic (years)   Age of NB onset (years)   Age of VF loss onset (years)   Age of cataracts onset (years)[\*](#t001fn002){ref-type="table-fn"}   Age at VA measurement   VA                                             VA classification^a^   Age at VF measurement   VF                                           VF classification^b^   Age at evaluation of fundus   Fundus                                                                                                                                                                                    ERG / Age (yr)                                                                                                                                           Other
  ------------ --------- --------------- --------------------------- ------------------------- ------------------------------ --------------------------------------------------------------------- ----------------------- ---------------------------------------------- ---------------------- ----------------------- -------------------------------------------- ---------------------- ----------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------
  I:2          RP-0030   1915            \-                          9yr                       9yr                            Yes at 74yr                                                           78yr                    perception of light                            3                      \-                      \-                                           \-                     78yr                          typical + pigment deposit in macula                                                                                                                                                       NR / 78yr                                                                                                                                                \-
  II:2         RP-0030   1938            \-                          5yr                       \-                             Yes (age unknown)                                                     6yr                     \-                                                                    71yr                    \<10° ct                                     3                      71yr                          typical (few spicules) + white yellowish spots in posterior pole                                                                                                                          NR / 71yr                                                                                                                                                \-
  II:5         RP-0030   1943            15yr                        8yr                       34yr                           36yr                                                                  46yr & 66yr             BE = 0.2 → hand movement                       1→2                    48yr                    10° ct                                       2                      66yr                          typical + macular atrophy and hypopigmented lesions                                                                                                                                       NR / 66yr                                                                                                                                                \-
  III:2        RP-0030   1968            \-                          7yr                       15yr                           32yr                                                                  40yr                    BE = 0.8                                       0                      40yr                    10° ct                                       2                      40yr                          Normal vessels, optic disc and macula. Nummular pigment deposits Vitreous floaters                                                                                                        Rods and mix: NR, cones and flicker: reduced amplitude / 40yr                                                                                            Hyperopia. Progressive hearing loss 36yr
  III:4        RP-0030   1971            \-                          5yr                       20yr                           38yr                                                                  20yr & 38yr             RE = 0.7→0.6LE = 1→0.7                         0                      20yr                    peripheral contraction with temporal islet   1                      20yr                          typical (few spicules) + hypopigmented lesions and vitreous floaters                                                                                                                      Sco and Pho: reduced amplitude of b wave / 20yr. NR / 38yr                                                                                               Progressive myopia
  III:6        RP-0030   1981            10yr                        3yr                       9yr                            \-                                                                    6yr                     RE = 0.7; LE = 1                               0                      10yr                    Ring scotoma                                 1                      \-                            \-                                                                                                                                                                                        Sco and Pho: reduced amplitude of b wave / 10yr                                                                                                          Progressive myopia
  III:2        RP-0711   1967            22yr                        14yr                      20yr                           No at 42yr                                                            30yr & 42yr             RE = 0.85→0.6 LE = 0.7→0.5                     0                      42yr                    10° ct                                       2                      25yr & 40yr                   1^st^ evaluation: tapetoretinal degeneration sine pigmenti 2^nd^ evaluation: typical + with chorioretinal degeneration                                                                    Rods and mix: reduced amplitude, cones and flicker: normal / 25yr                                                                                        \-
  III:4        RP-0711   1973            \-                          16yr                      \-                             \-                                                                    38yr                    RE = 0.7 LE = 0.5                              0                      20yr                    10° ct                                       2                      38yr                          Typical + mild degeneration of macular RPE                                                                                                                                                \-                                                                                                                                                       \-
  III:5        RP-0711   1979            30yr                        \-                        \-                             No at 30yr                                                            30yr                    BE = 0.8                                       0                      \-                      \-                                           \-                     30yr                          Normal vessels, and optic disc, few peripheral and perivascular spicules + degeneration of macular RPE                                                                                    NR /30yr                                                                                                                                                 \-
  III:6        RP-0711   1954            18yr                        Childhood                 40yr                           54yr                                                                  54yr                    RE = 0.8 LE = 0.6                              0                      \-                      \-                                           \-                     \-                            \-                                                                                                                                                                                        NR / 54yr                                                                                                                                                \-
  III:7        RP-0711   1952            24yr                        20yr                      \-                             45yr                                                                  57yr                    RE = 0.8                                       0                      57yr                    10° ct                                       2                      57yr                          (only RE) typical (few spicules, nummular pigment deposits) + degeneration of macular RPE                                                                                                 NR / 57yr                                                                                                                                                Enucleation of LE in childhood due to glioblastoma. Photopsia
  III:8        RP-0711   1958            \-                          \-                        \-                             No at 50yr                                                            50yr                    RE = 0.9 LE = 0.8                              0                      50yr                    10° ct                                       2                      \-                            Typical with conserved optic disc + degeneration of macular RPE                                                                                                                           NR / 50yr                                                                                                                                                \-
  IV:2         RP-0711   1991            12yr                        11yr                      11yr                           No at 12yr                                                            11yr &18yr              RE = 0.8→0.6 LE = 0.7→0.5                      0                      11yr                    30° ct                                       1                      11yr & 18yr                   1^st^ evaluation: tapetoretinal degeneration sine pigmenti Vitreous floaters 2^nd^ evaluation: Normal vessels, optic disc, macula and vitreous. Hypopigmented lesions in mid periphery.   Rods: NR, mix: reduced amplitude of a and b waves, cones and flicker: normal / 12yr. Rods and mix: NR, cones and flicker very reduced amplitude / 18yr   \-
  II:6         RP-1182   1950            51yr                        12yr                      \-                             51yr                                                                  54yr                    RE = 0.3 LE = 0.6                              1                      54yr                    Central & superior hemifield scotoma         1                      58yr                          Typical + degeneration of macular RPE and vitreous floaters                                                                                                                               NR / 58yr                                                                                                                                                \-
  III:8        RP-1182   1976            26yr                        26yr                      26yr                           31yr                                                                  31yr                    RE = 0.7 LE = 1                                0                      26                      RE = Nasal hemifield scotoma LE = Normal     1                      33yr                          Normal vessels, optic disc, macula. Nummular pigment deposits in periphery.                                                                                                               Rods, mix and flicker: NR, cones: very reduced amplitude / 33yr                                                                                          Myopia. Unilateral onset (RE)
  II:4         RP-0124   1935            57yr                        10yr                      10yr                           57yr [\*\*](#t001fn003){ref-type="table-fn"}                          57yr → 61yr             RE = 0.1 LE = 0.1                              2                      57yr                    RE 10° ct LE = absolute scotoma              3                      57yr                          Typical                                                                                                                                                                                   NR / 57yr                                                                                                                                                Astigmatism
  I:2          RP-0576   1957            38yr                        24yr                      28yr                           52yr                                                                  40yr & 52yr             RE = 0.7→0.2 LE = 0.9→0.2                      0→1                    38yr                    10° ct                                       2                      38yr                          Typical                                                                                                                                                                                   Rods, mix and flicker: NR, cones: very reduced amplitude / 38yr. NR / 40yr                                                                               \-
  I:2          RP-1650   \-              \-                          \-                        \-                             \-                                                                    60yr                    \-                                             2                      \-                      \-                                           \-                     \-                            \-                                                                                                                                                                                        \-                                                                                                                                                       \-
  II:2         RP-1650   1958            42yr                        \-                        \-                             \-                                                                    \-                      \-                                             \-                     \-                      \-                                           \-                     \-                            \-                                                                                                                                                                                        \-                                                                                                                                                       \-
  III:1        RP-1650   1978            27yr                        29yr                      25yr                           No at 25yr                                                            25yr                    BE = 0.6                                       0                      32                      \<20° ct                                     2                      32yr                          Typical                                                                                                                                                                                   Abnormal / 32yr                                                                                                                                          \-
  I:2          RP-1996   1924            \-                          \-                        \-                             \-                                                                    53yr                    (Neither perception nor projection of light)   \-                     \-                      \-                                           \-                     \-                            \-                                                                                                                                                                                        \-                                                                                                                                                       High IOP
  II:4         RP-1996   1953            48yr                        38yr                      48yr                           59yr                                                                  57yr→59yr               RE = 0.8→0.5; LE = 0.2                         1                      59                      \<10° ct                                     3                      59                            Degeneration of macular RPE + macular edema + peripheral spicules                                                                                                                         Sco, Pho and flicker: reduced amplitude of b wave / 57yr                                                                                                 High IOP
  III:3        RP-1996   1980            30yr                        20yr                      20yr                           32yr                                                                  32yr                    BE = 1                                         0                      30                      BE = temporal hemifield scotoma              1                      32                            Choroidal hypopigmentation (no spicules)                                                                                                                                                  \-                                                                                                                                                       FA: choroidal silence with granular alteration and macular pattern / 32yr

Yr: Years. VA: Visual Acuity. VF: Visual Field. Ct: Central. ERG: Electroretinogram. VEP: Visual Evoked Potential. FA: Fluorescein Angiography RPE: retinal pigment epithelium. RE: Right eyes. LE: Left eye. BE = both eyes. Sco = Scotopic. Pho = Photopic.

\* All patients with cataracts (except family RP-1996) presented: subcapsular posterior cataracts in BE.

\*\* Patients also presented cortical anterior cataract in BE.

\*\*\* VA after cataract surgery.

^\#^ The age at onset of cataracts is not available (mature cataract at diagnosis).

^\#\#^ Legal blindness. VA classification^a^: 0 = Normal vision (normal and near normal vision) (≥0.4), 1 = Moderate low vision (\<0.4 --\>0.1), 2 = Severe low vision (≤0.1--≥0.05, legal blindness), 3 = profound vision loss and blindness (blindness and near blindness, \<0.05). VF classification^b^ 0 = normal, 1 = peripheral and ring scotoma, peripheral constriction with VF ≥20°, 2 = \<20°--≥10° central, 3 = \<10° central. Typical fundus: optic disc pallor, attenuation of the retinal vessels and pigmentary deposits resembling bone spicules. IOP: Intraocular pressure. NR: Non recordable.

In most cases NB was the first noticeable symptom with an onset in pre-adolescence or early twenties (mean age 15.9 ± 10.1 years). Visual field (VF) loss onset was variable, although tubular vision onset tended to occur around the third decade of life (mean age 23.2 ± 11.9 years) and stayed stable until an advanced age. Loss of visual acuity (VA) appeared later in the disease´s evolution, being normal (≥0.4) until the fifth decade of life ([Table 2](#pone.0149473.t002){ref-type="table"}).

10.1371/journal.pone.0149473.t002

###### Phenotypic characteristics (means and standard deviation) of patients with the p.Gly56Arg mutation in *NR2E3*.

![](pone.0149473.t002){#pone.0149473.t002g}

  Age at diagnosis (yr)   NB Onset (yr)     VF loss Onset (yr)   Cataract (yr)              VA                                              VA (WHO severity)                            Fundus                     ERG                                                                                                    
  ----------------------- ----------------- -------------------- -------------------------- ----------------------------------------------- -------------------------------------------- -------------------------- --------------------------------------------- ------------------- ------------------ ----------------- ------------------
  **30.2 ± 14**           **15.9 ± 10.1**   **23.3 ± 11.9**      Yes = 14, No = 5, NA = 5   \<50yr **RE = 0.70 ± 0,17; LE = 0.72 ± 0.23**   \>50yr **RE = 0.3 ± 0,3; LE = 0.3 ± 0,3;**   \<50yr **Normal vision**   \>50yr **Moderate to profound vision loss**   **63.2%** (12/19)   **47.4%** (9/19)   **29.2 ± 13.9**   **54.55 ± 14.4**

Yr: Years. VA: Visual Acuity. VF: Visual Field. ERG: Electroretinogram. NA: Not Available. RE: Right Eye. LE: Left Eye. VA classification^a^: 0 = Normal vision (normal and near normal vision) (≥0.4), 1 = Moderate low vision (\<0.4 --\>0.1), 2 = Severe low vision (≤0.1--≥0.05, legal blindness), 3 = profound vision loss and blindness (blindness and near blindness, \<0.05). Typical fundus: optic disc pallor, attenuation of the retinal vessels and pigmentary deposits resembling bone spicules.

Only two patients presented legal blindness (VA ≤0.1 or VF ≤10°) at 60 and 71 years of age, respectively. Additionally, one patient with RP, who also presented glaucoma, was diagnosed with complete blindness (neither perception nor projection of light) at the age of 53.

More than half of the patients (58.3%) with available ophthalmological data presented cataract (73.7%), most of them (50%) since the third decade of life ([Table 2](#pone.0149473.t002){ref-type="table"}).

All ophthalmoscopic examination data available (19 patients) showed fundus alterations ([Fig 2](#pone.0149473.g002){ref-type="fig"}).

![Fundus Images: Each patient presents two fundus images per eye.\
A) Family RP-0030, B) Family RP-0576, C) Family RP-0711. \*Fundus image not available. \*\*Enucleation of the LE due to glioblastoma. RE = Right eye. LE = Left eye.](pone.0149473.g002){#pone.0149473.g002}

These fundus alterations could be detected since the beginning of the vision impairment, although visual acuity was not affected ([Table 1](#pone.0149473.t001){ref-type="table"}).

Although fundus changes showed inter and intrafamiliar variability, most of the patients showed typical RP changes with the progression of the disease. It was also frequent to find macular affectation (47.4% -[Table 2](#pone.0149473.t002){ref-type="table"}-) with preserved visual acuity, even when patients were studied in the first stages of the disease (family RP-0711, IV:2 -[Table 1](#pone.0149473.t001){ref-type="table"}-).

ERG recordings were available for 19 cases. All available ERG recordings (scotopic, photopic and flicker) showed alterations from the beginning of the disease, and these changes could be detected around the first decade of life, when studied at that age (family RP-0711 patient IV:2; and family RP-0030 patient III:6---[Table 1](#pone.0149473.t001){ref-type="table"} and [S1 Fig](#pone.0149473.s001){ref-type="supplementary-material"}). Non recordable ERG occurred around the age of fifty ([Table 2](#pone.0149473.t002){ref-type="table"}). Similarly as for fundus changes, the initial impairment in ERG recordings did not seem to alter visual acuity.

Haplotype analysis {#sec013}
------------------

Four of the families (RP-0030, RP-0576, RP-0711 and RP-1182) belonged to the same town in Spain (in the Toledo region, with 2755 inhabitants in 1920 and 3511 inhabitants in 2010, according to the demographic data of the Instituto Nacional de Estadística -INE- [http://www.ine.es](http://www.ine.es/)). In two of these families, RP-0030 and RP-1182, a common ancestor (four generations above the respective family probands) could be identified, but not in RP-0711 and RP-0576 (family trees investigated five generations above the respective probands, [Fig 3](#pone.0149473.g003){ref-type="fig"}).

![Pedigrees and Haplotype analysis of adRP families with p.Gly56Arg mutation in *NR2E3*.\
Haplotype analysis: → marks the *NR2E3* gene position. The *NR2E3* extragenic polymorphic markers used are D15S967, D15S1050, D15S204 and D15S188.](pone.0149473.g003){#pone.0149473.g003}

Inferring haplotypes in families RP-1650 and RP-0124 (and even in RP-1996) is very speculative. However, the two large families belonging to the same village (RP-0030, RP-0711) shared a common haplotype for the four flanking biomarkers \[D15S976 (157bp allele)---D15S1050 (289 bp allele)---D15S204 (127 bp allele)---D15S188 (403 bp allele)\] linked to the mutation and RP-1182 shared the same haplotype for the markers D15S976-D15S1050-D15S204. Besides, RP-0124 and RP-1650 families shared a common haplotype defined by the two flanking markers D15S1050 (289bp allele) and D15S204 (127bp allele) whereas the other two families, one from the same city (RP-0576) and RP1996 showed the same proximal marker (D15S1050 289bp) but differed in the distal one (D15S204 119bp allele) indicating that at least two independent mutational events or alternatively a postmutational recombination event, might have occurred ([Fig 3](#pone.0149473.g003){ref-type="fig"}).

So, D15S1050 (289bp allele), the closest microsatellite to *NR2E3* gene, is shared by all patients, leaving a small region of 104Kb comprised between D15S1050 (ensemble genomic position Crh15: 71,980,969--71,981,252) and the *NR2E3* gene (ensemble genomic position Crh15: 72,084,977--72,110,600), which could be common to all of the patients carrying p.Gly56Arg mutation.

Discussion {#sec014}
==========

This paper is an extensive report of frequency of the mutation (p.Gly56Arg) in the *NR2E3* gene in 24 cases diagnosed of adRP, and the associated phenotype.

The prevalence for this mutation in our present cohort of adRP families is 3.5% which is similar to the rates described in Europe (3.4%) \[[@pone.0149473.ref017]\], but higher than those described in North America \[[@pone.0149473.ref019]\].

In our cohort of adRP families, the p.Gly56Arg mutation is the second most common single mutation detected \[[@pone.0149473.ref024]\] after the p.Pro347Leu mutation in the *RHO* gene which was found in nine families out of 200, representing a 4.4% \[[@pone.0149473.ref025]\].

The results of the haplotype analysis are conclusive for the two most informative families belonging to the same small village ([Fig 3](#pone.0149473.g003){ref-type="fig"}). We found a common haplotype in those families for the four markers and for three of them in the family RP-1182. These data support an ancient founder effect for the p.Gly56Arg in our families. However one must be cautious because i) one out of four families coming from the same small geographical area did not share the common haplotype. This fact is unexpected and despite there being an association between the 289 allele of D15S1050 and p.Gly56Arg, D15S1050 and *NR2E3* are in different disequilibrium blocks, we have to consider that the Spanish population is underrepresented in the Hapmap project and that the allele 289 has a frequency of 0.519 (<http://www.genoscope.cns.fr/externe/gmap/Nature-1995/>), so the probability that both the allele 289 and the mutation are located in the chromosome is very high. Furthermore, there are no hot spot recombination sites like the common motif CCNCCNTNNCCNC \[[@pone.0149473.ref026]\] within the *NR2E3* gene and their 5' and 3' UTR regions that could explain the lack of a common ancestral haplotype by a high recombination rate, ii) The frequency of p.Gly56Arg in populations that have evolutionary diverged, such as American, European and Chinese, are high and quite similar (1.2% in American \[[@pone.0149473.ref019]\], 3.4% in European \[[@pone.0149473.ref017]\] and 1.2% in China \[[@pone.0149473.ref027]\]) and iii) the mutation c.166G\>A is a change GGG\>AGG in codon 56 of *NR2E3*. This change lies on a CpG dinucleotide and has been reported as high *de novo* mutation site. In fact, the most common *de novo* mutated codon associated with human disease is a GGG\>AGG or CGG mutation in codon 380 of *FGFR3* gene \[[@pone.0149473.ref028], [@pone.0149473.ref029]\] which results in achondroplasia. In summary, it is tempting to speculate that the p.Gly56Arg arose once in our population as a very ancient hit giving time for a number of recombination events that have led to the change in the ancient haplotype.

The *NR2E3* gene is associated with both autosomal recessive and dominant retinitis pigmentosa. The *NR2E3* gene recessive mutations present variable phenotypes (ESCS, GFS and CPRD) with variable ophthalmological findings, but all showing night blindness, rudimental or absent rod function, and hyperfunction of the \"blue\" S-cones \[[@pone.0149473.ref014], [@pone.0149473.ref020], [@pone.0149473.ref030]\]. Dominant *NR2E3* gene mutation has been associated with RP phenotype \[[@pone.0149473.ref017]--[@pone.0149473.ref020]\] and to date, the phenotype has only been described in five European \[[@pone.0149473.ref017], [@pone.0149473.ref018], [@pone.0149473.ref020]\] and four North American \[[@pone.0149473.ref019]\] families characterized by presenting RP, but not to other phenotypes associated to *NR2E3* gene recessive mutations \[[@pone.0149473.ref016], [@pone.0149473.ref017]\]. However, some affected members of those families displayed phenotypic similarities to ESCS \[[@pone.0149473.ref017], [@pone.0149473.ref020]\].

Although we observe, as it has been previously described \[[@pone.0149473.ref018]\], inter and intrafamiliar phenotype variability for the p.Gly56Arg mutation, some genotype-phenotype correlation appears to be quite apparent, not only homogeneous progression \[[@pone.0149473.ref019]\], but occurrence of vision impairment milestones. Patients with *NR2E3* dominant mutation showed a moderate form of retinal dystrophy. Thus, patients in our cohort present early NB onset around puberty, preservation of VF\>10° until the 4^th^-5^th^ decade of life, normal or moderately low VA (WHO criteria) to an advanced age and preservation of photoreceptor function (recordable ERG) until the 4^th^ decade of life ([Table 2](#pone.0149473.t002){ref-type="table"}).

It is important to notice that this phenotype is milder than the one found in recessive forms \[[@pone.0149473.ref018]\] and to point that the fundus alterations (additionally to typical RP fundus, atypical findings are present as macular changes and choriocapillaris atrophy) and ERG findings (impaired photopic and flicker records in the first stages of the disease) observed in some of our patients, are not the classical RP changes previously described in the European and North American *NR2E3* dominant patients \[[@pone.0149473.ref017], [@pone.0149473.ref019], [@pone.0149473.ref020]\].

Moreover these changes did not seem to correlate with visual acuity impairment, at least during the first stages of the disease (impaired ERG and fundus changes with normal VA). However the absence of correlation between ERG and VA is common in RP patients \[[@pone.0149473.ref001]\].

These fundus changes have recently been described on the ophthalmoscopic findings of *NR2E3* ESCS (recessive) patients. These changes can lead to a misdiagnosis if family history, initial symptoms reported by patients and progression of the disease in the early stages are not queried when performing the clinical history. Besides, other ophthalmological signs such as double concentric autofluorescence ring (not performed in our cohort), that has been described as an initial sign of retinal degeneration in patients carrying the *NR2E3* dominant mutation \[[@pone.0149473.ref020]\], could help in the molecular diagnostic orientation of adRP patients.

Furthermore, some of these changes such as macular edema, can, at least partially, be treated \[[@pone.0149473.ref031], [@pone.0149473.ref032]\], which is important for prognosis, disease outcome and follow up of these patients. Although this event was only observed in one of our patients by ophthalmoscopic examination, we cannot discard that it could be present in other NR2E3 adRP patients, as no OCT data was available for the present cohort.

Conclusion {#sec015}
==========

We believe that the relevance of this study is not only being the single largest *NR2E3* genotype-phenotype correlation study performed to date, but also highlighting the importance of p.Gly56Arg in the *NR2E3* gene associated to adRP.

*NR2E3* is responsible for two main retinal phenotypes ESCS (including Goldmann-Favre syndrome) only for recessive forms and RP (including CPRD) related to both dominant and recessive forms. However, in our cohort there is a wide range of phenotypic characteristics that differ from typical RP phenotype and resemble other *NR2E3* phenotypes such as ESCS and CPRD, mainly at a fundus level where we found macular disturbance, which is frequently seen in ESCS, in 50% of our evaluated patients and two patients with nummular pigmentation (typical of CPRD phenotype).

In this report, we are providing new clues of a characteristic phenotype for this mutation that allows for making an estimated prognosis of autosomal dominant RP due to p.Gly56Arg mutation in the *NR2E3* gene. Besides, we believe that this study can improve molecular diagnosis approach, clinical management, risk assessment, and genetic counselling of adRP patients and their families.

Supporting Information {#sec016}
======================

###### Electroretinogram (ERG) recording in IV:2 member of RP-0711 family.

A\) ERG at 11years of age. B) ERG at 18 years of age.

(DOCX)

###### 

Click here for additional data file.
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